Shares of Oric Pharmaceuticals sank 40% Wednesday after the cancer biotech reported study results that were positive--but not positive enough for Wall Street. In an early-stage trial, Oric’s prostate- ...
It’s Like Poetry (Thursday Crossword, April 2) ...
The S&P 500’s performance on Wednesday has been led by some of the biggest makers of the infrastructure needed for artificial ...
President Trump's trade war triggered the first year-over-year decline in U.S. coal exports since 2020, largely due to a 92% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results